Designs for Health gains backing from BDT & MSD Partners

Designs for Health, the practitioner-focused supplements maker, has accepted a strategic minority equity investment from funds affiliated with BDT & MSD Partners, the company announced today. The injection of patient capital is aimed at accelerating product research, fortifying clinical education for healthcare professionals and scaling commercial capabilities.

The transaction continues a lineage of private capital supporting the firm: RoundTable Healthcare Partners — a prior partner — has worked with the company for several years. Financial terms were not disclosed. Founder and Executive Chairman Jonathan Lizotte will retain majority ownership and will remain at the helm as the business expands its science-led portfolio.

Founded more than 36 years ago, Designs for Health has built a reputation among clinicians for evidence-first formulations and practitioner education. The new minority sponsor brings a long-horizon investing approach designed to back founder-led companies; its capital is expected to support R&D, manufacturing quality controls, and expanded clinical programming aimed at improving patient outcomes.

In a statement, Byron Trott, Chairman & Co-CEO of BDT & MSD, said the firm values founder stewardship and long-term growth plans. Market observers view the deal as emblematic of a wider trend: specialist consumer health brands that serve clinicians are attracting non-traditional private capital because they combine steady revenues with strong category tailwinds in functional nutrition.

Industry context underscores the strategic logic. The global market for dietary supplements and functional nutrition has been expanding at mid-single-digit rates as clinicians and consumers increase demand for evidence-backed products and personalised nutritional strategies. For a company that sells primarily through healthcare professionals, investment in clinical training, digital tools and supply-chain resilience can unlock new distribution lanes without sacrificing quality standards.

Practically, the fresh capital should enable Designs for Health to accelerate formulation science, invest in manufacturing and broaden its educational footprint for practitioners — areas the company has emphasised as core differentiators. Retaining founder leadership while bringing an institutional partner aligns incentives around long-term brand health rather than a quick exit.